News
Moreover, Eskreis-Winkler and team pointed out that AI-directed MRI protocols can save valuable time. For example, they ...
The 59-year-old CEO of Sermo is running relentlessly in an effort to raise $1 million for stem cell transplant research.
Results from a new study help resolve the decade-long mystery of why many patients with the deadliest form of skin cancer do ...
Colorectal cancer offered the earliest window into the trend of increased cancer incidence among those younger than age 50.
A newly developed molecular imaging technique can identify multiple subtypes of triple-negative breast cancer (TNBC), ...
This article is authored by Dr Robin Mendelsohn, MD, gastroenterologist, Memorial Sloan Kettering Cancer Center.
For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus FLOT yields better outcomes than FLOT alone.
Immunotherapy combined with chemo can give people a fighting chance against stomach and esophageal cancers, a new clinical ...
“And you’re going to be treated at Memorial Sloan Kettering Cancer Center.” Jan Claire supported her younger sister as she underwent chemotherapy, surgery, and radiation to treat triple negative ...
It’s important to know the difference between colitis and ulcerative colitis because treatment for these conditions can ...
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.
New research suggests that an antibody-drug conjugate may offer practice-changing, patient-friendly treatment of blastic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results